ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs MXN
16.6167
-0.03%
Brent Oil
82.105
-0.41%
Bitcoin
69,854.81
-0.39%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Chelsea Therapeutics International, Ltd. (MM) (CHTP)

  7. Chelsea Therapeutics International, Ltd. (MM) (CHTP) Noticias

CHTP

Chelsea Therapeutics International, Ltd. (MM) (CHTP)

Chelsea Therapeutics International, Ltd. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CHTP
FechaHoraFuenteTítuloSímboloCompañía
03/07/201409:14Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
25/06/201415:46Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
25/06/201415:12Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
24/06/201405:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
23/06/201415:48Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
23/06/201415:35Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
23/06/201415:13Edgar (US Regulatory)(25-NSE)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
19/06/201415:30GlobeNewswire Inc.NORTHERA(TM) Clinical Trial Data Published in NeurologyNASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
12/06/201406:30GlobeNewswire Inc.Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Move...NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
06/06/201406:00GlobeNewswire Inc.Chelsea Therapeutics Announces the Expiration of the Hart-Scott-Rodino Waiting Period in Relation to the Proposed Acquisition...NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
02/06/201414:32PR Newswire (US)The Law Office of Robbins Arroyo LLP Announces Class Action Lawsuit Against Chelsea Therapeutics International, Ltd.NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
28/05/201414:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
23/05/201415:54Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
23/05/201415:16Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
21/05/201409:58Business WireChelsea Therapeutics Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate the Acquisition Pr...NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
12/05/201410:44PR Newswire (US)Acquisition Chelsea Therapeutics International, Ltd by H. Lundbeck A/S May Not Be in Shareholders' Best InterestsNASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
12/05/201408:05Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
09/05/201420:15Business WireSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Chelsea Therapeutics International, Ltd.NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
09/05/201419:40PR Newswire (US)Harwood Feffer LLP Announces Investigation of Chelsea Therapeutics International, Ltd.NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
09/05/201418:51PR Newswire (US)Lifshitz & Miller Law Firm Announces Investigation of Chelsea Therapeutics International Ltd., KBR, Inc., OmniAmerican Bancor...NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
09/05/201415:49Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
09/05/201409:35PR Newswire (US)Ryan & Maniskas, LLP Announces Investigation of Chelsea Therapeutics International Ltd.NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
09/05/201409:08Business WireNewman Ferrara LLP Announces Investigation of Chelsea Therapeutics International Ltd.NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
09/05/201408:11PR Newswire (US)Law Offices of Marc S. Henzel Announces Securities Class Action PeriodsNASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
08/05/201420:00Business WireSHAREHOLDER ALERT: Brower Piven Announces the Investigation of Chelsea Therapeutics International, Ltd. in Connection with th...NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
08/05/201417:35Business WireLaw Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. StockholdersNASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
08/05/201416:25PR Newswire (US)SHAREHOLDER ALERT: The Law Office of James C. Kelly Investigates Claims That the Proposed Acquisition of Chelsea Therapeutics...NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
08/05/201416:12Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
08/05/201416:09PR Newswire (US)INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Di...NASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
08/05/201412:21Business WireCHELSEA THERAPEUTICS INTERNATIONAL, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of BuyoutNASDAQ:CHTPChelsea Therapeutics International, Ltd. (MM)
 Showing the most relevant articles for your search:NASDAQ:CHTP

Su Consulta Reciente

BIT
F05833
Vontobel Financial Produ...
NYSE
POND.U
Angel Pond
COIN
GRMDEUR
UNSW3
UNIIETH
UNII
BIT
UB3ZE9
Unicredit Bank
BIT
UC8K3G
Unicredit Bank
LSE
46WQ
Investec Bnk 23
USOTC
ATHJF
Percheron Therapeutics (PK)
USOTC
ADBKF
Addiko Bank (PK)
BIT
P1MD29
BNP Paribas Issuance
BIT
UC92TL
Unicredit Bank
USOTC
HLOC
Helo (PK)
BOV
ABEVF15
ABEVF15 Ex:14,2
AMEX
SCHA
Schwab US Small Cap
LSE
SEQC
USOTC
NWBTF
Newborn Town (PK)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados